TBC

15:15 Welcome

L. Arias SPAIN

15:17 Clinical and genetic landscape of patients with inherited retinal diseases (IRD) in a European reference network member

V. Murro ITALY

15:23 Clinical outcomes of RPE65-related inherited retinal dystrophy patients treated with Voretigene Neparvovec gene therapy: the experience of Careggi Hospital

S.V. Sadda USA

15:29 52 Week Safety and Efficacy of Optogenetic Therapy for Vision Restoration in Retinitis Pigmentosa Patients

K. Lisbjerg DENMARK

15:35 Disease progression of PRPF31-associated retinitis pigmentosa in a Nordic population: A retrospective study with up to 36 years follow-up

M. Großpötzl AUSTRIA

15:41 Progression of Stargardt disease type 4 as measured by spectral-domain optical coherence tomography (SD-OCT) in the ProgStar-4 Study

F. Romano ITALY

15:47 Microperimetry Assessment in Extensive Macular Atrophy with Pseudodrusen-like appearance (EMAP)

L. Colombo ITALY

15:53 Molecular Epidemiology in 591 Italian Probands With Nonsyndromic Retinitis Pigmentosa and Usher Syndrome

E. Panagiotou GREECE

15:59 Studying the genetic basis of inherited retinal diseases (IRDs) in Greece: preliminary results

All Faculty

16:05 Discussion